Delcath Systems (DCTH) Reports Q4 Loss of $0.31/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. ANT
3. SPY
4. META
5. FFAI
6. FFR
7. CART
8. LLY
9. TSLA
10. AZN

Go back to Delcath Systems (DCTH) Reports Q4 Loss of $0.31/Share

Delcath Reports 2014 Fourth Quarter And Full Year Financial Results

March 10, 2015 4:30 PM EDT

NEW YORK, March 10, 2015 /PRNewswire/ -- Delcath Systems, Inc. (NASDAQ: DCTH), a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of primary and metastatic liver cancers, announces financial results for the three and 12 months ended December 31, 2014. 

Highlights of 2014 and recent weeks include:

Opened for enrollment a global Phase 2 clinical trial program for Melphalan/HDS for first-line treatment of patients with unresectable hepatocellular carcinoma (HCC) or primary liver cancer at leading cancer centers in Europe and at the Moffitt Cancer... More